South China Morning Post · General

China biotech flow picks up as Everest seals US$250 million deal

· By Julie Zhang
Story summary

Sovereign wealth funds from Singapore and Abu Dhabi join Chinese state capital as cross-border biotech licensing reaches record highs

Read at South China Morning Post

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.

Your local edition.

Choose a timezone for story timestamps and date filters.